Abstract
No decisively-effective medicine has been found for complaints manifested during the early phase of cold. The disirable medicine should relieve these complaints and restore normal functions of the organs. The medicine is also expected to take effect in relatively short time and to keep its efficacy for a certain period with few side action.
Newly developed Contac 600 was tried for this purpose on 100 patients who visited our out patient clinic.
All patients were seen within 24 hours following onset of the cold symptoms. Fifty six of them were followed and results were analized. In summary 83.9% of the patients revealed objective clinical improvement while 87.3% showed subjective benifits.
